APTN
ADAPTIN BIO, INC.Company Information
- Company Name
- ADAPTIN BIO, INC.
- CIK
- CIK0001938571
- Category
- <br>Emerging growth company
- Ticker: Exchange
- APTN: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- APTN
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- —
- Price on filing date
- —
- 1-month reaction
- —
- 3-month reaction
- —
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | ||||||
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 0 | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Prepaid Expense Current | - | 0 | - | - | 0 | 0 | - | - | - | - | - | - | ||||||
| Assets Current | 1 | 1 | 1 | 1 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 1 | 1 | 1 | 1 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Deferred Costs | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
Liabilities Current | ||||||||||||||||||
| Notes Payable Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Current | 2 | 1 | 2 | 1 | 1 | 0 | 1 | - | - | - | - | - | ||||||
| Other Notes Payable Current | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | - | - | ||||||
| Convertible Debt Current | - | - | - | - | - | - | 1 | - | - | - | - | - | ||||||
| Derivative Liabilities Current | - | - | - | - | - | - | 1 | - | - | - | - | - | ||||||
| Interest Payable Current | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Current | 3 | 2 | 2 | 2 | 1 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 3 | 2 | 2 | 2 | 1 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 10 | 9 | 8 | 7 | 7 | 6 | 0 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -12 | -10 | -9 | -8 | -6 | -5 | -4 | -0 | -0 | -0 | -0 | -0 | ||||||
| Stockholders Equity | -2 | -2 | -1 | -1 | 0 | 2 | -4 | -3 | -2 | -1 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Common Stock Shares Issued | 9 | 9 | 9 | 8 | 8 | 8 | 3 | 5 | 5 | 5 | 5 | 5 | ||||||
| Shares Outstanding | 9 | 9 | 9 | 8 | 8 | 8 | 3 | 5 | 5 | 5 | 5 | 5 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialADAPTIN BIO, INC. (APTN) — SEC Financial Statements & Analysis
ADAPTIN BIO, INC. (APTN) is a biological products, (no diagnostic substances) company, incorporated in DE. ADAPTIN BIO, INC. trades on OTC as: APTN. ADAPTIN BIO, INC. (APTN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, ADAPTIN BIO, INC. carries a market cap of $55.04M, a P/E ratio of -10.20x, a P/B ratio of -33.05x, an enterprise value of $54.37M, and an EV/EBITDA multiple of -10.09x. On profitability, it posts a Return on Equity (ROE) of 906.01% and a Return on Assets (ROA) of -408.08%. Per share, it reports EPS of $-0.61, diluted EPS of $-0.61, free cash flow per share of $-0.28, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 31.96% year-over-year and EPS growth of 26.08% year-over-year. On the balance sheet, it maintains a current ratio of 0.37x, a quick ratio of 0.25x, working capital of $-1.67M, a debt-to-equity ratio of -1.59x, a debt ratio of 2.7, an interest coverage ratio of -811.63x, free cash flow of $-2.52M (TTM), and net debt of $-670.49K. Figures sourced from SEC EDGAR.
- Market Cap
- $55.04M
- P/E TTM
- -10.20x
- EPS TTM
- $-0.61
- P/B TTM
- -33.05x
- ROE TTM
- 906.01%
- ROA TTM
- -408.08%
- Debt To Equity
- -1.59x
- Free Cash Flow TTM
- $-2.52M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ADAPTIN BIO, INC. in?
ADAPTIN BIO, INC. (APTN) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does APTN trade on?
ADAPTIN BIO, INC. (APTN) trades on the OTC.
Where is ADAPTIN BIO, INC. incorporated?
ADAPTIN BIO, INC. is incorporated in DE.
When was ADAPTIN BIO, INC. (APTN)'s most recent SEC filing?
ADAPTIN BIO, INC. (APTN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is APTN's market cap?
ADAPTIN BIO, INC. (APTN) has a market capitalization of $55.04M as of 2026-06-30.
What is APTN's EPS (earnings per share)?
ADAPTIN BIO, INC. (APTN)'s trailing twelve month EPS is $-0.61 as of 2026-06-30.
What is APTN's ROE (return on equity)?
ADAPTIN BIO, INC. (APTN)'s trailing twelve month Return on Equity (ROE) is 906.01% as of 2026-06-30.
What is APTN's ROA (return on assets)?
ADAPTIN BIO, INC. (APTN)'s trailing twelve month Return on Assets (ROA) is -408.08% as of 2026-06-30.
What is APTN's EV/EBITDA?
ADAPTIN BIO, INC. (APTN)'s trailing twelve month EV/EBITDA is -10.09x as of 2026-06-30.